
Ask a doctor about a prescription for CORTCAL 50 micrograms/g + 0.5 mg/g OINTMENT
Package Leaflet: Information for the Patient
Cortcal 50 micrograms/g + 0.5 mg/g ointment
calcipotriol/betamethasone
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information
Contents of the pack and further information
Cortcal is used on the skin to treat plaque psoriasis (psoriasis vulgaris) in adults. The cause of psoriasis is the excessively rapid production of your skin cells. This causes redness, scaling, and thickening of your skin.
Cortcal contains calcipotriol and betamethasone. Calcipotriol helps to normalize the rate of growth of your skin cells and betamethasone reduces inflammation.
Do not use Cortcal:
Since this medicine contains a potent steroid, DO NOT use it on skin affected by:
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with calcipotriol/betamethasone ointment if:
Special precautions
Contact your doctor if you experience blurred vision or other visual disturbances.
Children
Cortcal is not recommended for use in children under 18 years of age.
Using Cortcal with other medicines
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription.
Pregnancy, breastfeeding and fertility
Do not use calcipotriol/betamethasone ointment if you are pregnant (or think you may be pregnant) or if you are breastfeeding, unless you have previously agreed this with your doctor. If your doctor agrees that you can breastfeed, be careful and do not apply calcipotriol/betamethasone ointment to the breast area.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
This medicine does not affect your ability to drive or use machines.
Follow your doctor's instructions for using this medicine exactly. If you are unsure, consult your doctor or pharmacist again.
How to apply this medicine: For cutaneous use.
Instructions for proper use
Duration of treatment
If you are using other medicines that contain calcipotriol, the total amount of medicines containing calcipotriol should not exceed 15 grams per day and the treated area should not exceed 30% of the total body surface area.
What to expect when using Cortcal
Most patients notice obvious results after 2 weeks, even if the psoriasis has not completely cleared up at that time.
If you use more Cortcal than you should
Consult your doctor if you have used more than 15 grams in one day.
Excessive use of calcipotriol/betamethasone ointment may cause a problem with the calcium in your blood, which usually returns to normal when treatment is stopped.
Your doctor may need to perform blood tests to check that using too much ointment has not caused a problem with the calcium in your blood.
Prolonged and excessive use may also cause your adrenal glands to stop working properly (these are located near the kidneys and produce hormones).
If you have used more calcipotriol/betamethasone ointment than you should, consult your doctor, pharmacist, or call the Toxicology Information Service, telephone: 91 562 04 20, stating the medicine and the amount used.
If you forget to use Cortcal
Do not use a double dose to make up for forgotten doses.
If you stop treatment with Cortcal
Use of this medicine should be stopped as indicated by your doctor. It may be necessary to gradually stop using this medicine, especially if you have been using it for a long time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Tell your doctor/nurse immediately or as soon as possible if you suffer from any of the following side effects. You may need to stop your treatment.
The following serious side effects have been reported for calcipotriol/betamethasone:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
It is known that some serious side effects are caused by betamethasone (a potent steroid), one of the components of this medicine. If you suffer from any of these serious side effects, tell your doctor as soon as possible. These side effects are more likely to occur after long-term use, when used in skin folds (e.g. groin, armpits, or under the breasts), when covered, or when used on large areas of skin.
Side effects include the following:
Serious side effects caused by calcipotriol
Less serious side effects
The following less serious side effects have been reported for calcipotriol/betamethasone:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Frequency not known (frequency cannot be estimated from the available data)
Less serious side effects caused by the use of betamethasone, especially during prolonged use, include the following. If you notice any of these, tell your doctor or nurse as soon as possible.
Less serious side effects caused by calcipotriol include
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that they are not listed in this leaflet. You can also report side effects directly through the Medicines Monitoring System https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and tube after EXP. The expiry date is the last day of the month stated.
Do not store above 25°C. Do not refrigerate or freeze.
The tube should be discarded 1 year after first opening. Write the date of first opening on the space provided on the carton.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy for proper disposal. If you are unsure, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
Composition of Cortcal
One gram of ointment contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate).
Appearance and packaging
Cortcal is a white ointment.
The ointment is available in aluminum/epoxyphenol tubes with a screw cap made of polyethylene or polypropylene.
Package sizes: tubes containing 15 g, 30 g, 60 g, or 120 g of ointment.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Galenicum Derma, S.L.
Crta N-1, Km 36,
28750 San Agustin de Guadalix (Madrid)
Spain
Manufacturer
Lek Pharmaceuticals d.d.
Verovskova ulica, 57
1526 Ljubljana
Slovenia
or
Salutas Pharma GmbH
Lange Goehren 3
D-39171, Suelzetal
Germany
or
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben Germany
Date of last revision of this leaflet: November 2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of CORTCAL 50 micrograms/g + 0.5 mg/g OINTMENT in November, 2025 is around 44.69 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CORTCAL 50 micrograms/g + 0.5 mg/g OINTMENT – subject to medical assessment and local rules.